Assay range: 2-128 pg/ml
Sensitivity: 2 pg/ml
Calibration: rec. rhesus macaque IL-2
Type of sample: serum, plasma, culture supernatant
Sensitivity: 2 pg/ml
Calibration: rec. rhesus macaque IL-2
Type of sample: serum, plasma, culture supernatant
Catalogue Number
CT142A
Description
Monkey IL-2 ELISA kit - 5-plate
Price
€ 485.00
Contents
- coating antibody
- biotinylated detection antibody
- Cytokine standard (5x)
- Streptavidin-HRP (SPP) conjugate
- TMB substrate solution
- Stop solution
- Cytokine stabilization buffer (CSB)
- BSA stock solution (10%)
- Tween-20
- ELISA plates with cover slips
specificity
- rhesus macaque
- Cynomolgus monkey
- Pig-tailed macaque
- barbary macaque
- Baboon
- african green monkey
References list
- Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic.
- Immune senescence in old and very old rhesus monkeys: reduced antibody response to influenza vaccination.
- Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection.
- Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge.
- Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys.
- Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine.
- Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta.
- Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection.
- Constitutive release of IFNγ and IL2 from peripheral blood mononuclear cells of rhesus macaques (Macaca mulatta) infected with simian T-lymphotropic virus type 1.
- Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.